Kuzbicki et al. (48) found that the average level of COX-2 expression in melanoma samples was significantly higher than that in benign nevi, and COX-2 expression in tumor tissues with lymph node metastasis was significantly higher than that in non-metastatic melanoma (48). The gene discussed is PTGS2; the disease is metastatic melanoma.